(19)
(11) EP 4 577 568 A2

(12)

(88) Date of publication A3:
04.04.2024

(43) Date of publication:
02.07.2025 Bulletin 2025/27

(21) Application number: 23858316.5

(22) Date of filing: 24.08.2023
(51) International Patent Classification (IPC): 
C07K 16/18(2006.01)
A61P 35/00(2006.01)
A61K 47/68(2017.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/44; C07K 2317/24; C07K 2317/565; C07K 2317/622; C07K 2317/55; C07K 2319/31
(86) International application number:
PCT/US2023/072852
(87) International publication number:
WO 2024/044709 (29.02.2024 Gazette 2024/09)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 24.08.2022 US 202263373367 P
21.08.2023 US 202363520689 P

(71) Applicant: The Research Foundation for The State University of New York
Amherst, NY 14228-2577 (US)

(72) Inventors:
  • BALTHASAR, Joseph, P.
    Lancaster, NY 14086 (US)
  • BORDEAU, Brandon, M.
    West Seneca, NY 14224 (US)
  • NGUYEN, Toan, Duc
    Williamsville, NY 14221 (US)
  • POLLI, Joseph, Ryan
    Cambridge, MA 02139 (US)

(74) Representative: FRKelly 
Waterways House Grand Canal Quay
Dublin D02 PD39
Dublin D02 PD39 (IE)

   


(54) ANTI-MONOMETHYL AURISTATIN ANTIBODIES AND ANTIBODY FRAGMENTS